Michael G. Lemoine

655 citations
7 papers · 532 indexed · h-index 7
Topics
Virus-based gene therapy research (5 papers)RNA Interference and Gene Delivery (4 papers)CAR-T cell therapy research (4 papers)
Partner nations
United StatesSpain

In The Last Decade

Michael G. Lemoine

7 papers receiving 523 citations

Peers

Michael G. Lemoine
Comparison fields: 5 of 49
  • Genetics 349
  • Molecular Biology 299
  • Oncology 278
  • Pharmacology 89
  • Cancer Research 68
Replace Serguei R. Romanov with:
Serguei R. Romanov United States
Lu-Zhe Pan Canada
Maria Isabel Carvalho Portugal
Teresa P. Raposo United Kingdom
Alois Walder Austria
Bettina Fleischmann-Mundt Germany
Ron Rodriguez United States
Deborah Yebon Kang South Korea
Tatsuo Umeoka Japan
Nancy Yen United States
Michael G. Lemoine relative to Serguei R. Romanov United States Serguei R. Romanov's profile →
Citations per field
00.5×8.1×
Serguei R. Romanov · 1×
Citations per year

Countries citing papers authored by Michael G. Lemoine

Since Specialization
Citations

This map shows the geographic impact of Michael G. Lemoine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael G. Lemoine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael G. Lemoine more than expected).

Fields of papers citing papers by Michael G. Lemoine

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael G. Lemoine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael G. Lemoine. The network helps show where Michael G. Lemoine may publish in the future.

Co-authorship network of co-authors of Michael G. Lemoine

This figure shows the co-authorship network connecting the top 25 collaborators of Michael G. Lemoine. A scholar is included among the top collaborators of Michael G. Lemoine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael G. Lemoine. Michael G. Lemoine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
#WorkIndexed citations
1 37
2 15
3 16
4 46
5 272
6 22
7 124

About Michael G. Lemoine

Michael G. Lemoine is a scholar working on Oncology, Genetics and Cancer Research, having authored 7 papers that have together received 532 indexed citations. Recurring topics across this work include Virus-based gene therapy research (5 papers), RNA Interference and Gene Delivery (4 papers) and CAR-T cell therapy research (4 papers). The work is most often cited by research in Genetics (349 citations), Oncology (278 citations) and Biotechnology (58 citations). Michael G. Lemoine has collaborated with scholars based in United States and Spain. Frequent co-authors include Candelaria Gomez‐Manzano, Juàn Fueyo, Hong Jiang, Ramón Alemany, Charles A. Conrad, Gregory N. Fuller, Asad Ullah Khan, Raymond Sawaya, Ta-Jen Liu and Kaori Suzuki. Their work appears in journals such as Gastroenterology, JNCI Journal of the National Cancer Institute and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026